Posted BY: | NwoReport

The American College of Obstetricians and Gynecologists (ACOG) received $11.8 million from the Department of Health and Human Services (HHS) to promote COVID-19 vaccines to pregnant women, even though clinical trials had excluded pregnant women and there was limited safety data regarding vaccine use during pregnancy. Dr. James Thorp, a board-certified obstetrician-gynecologist, initiated a Freedom of Information Act (FOIA) request in 2022 to investigate the funding and motivation behind ACOG’s guidance on COVID-19 vaccines for pregnant women.

Documents obtained through the FOIA request revealed that ACOG had received cooperative agreement grants from HHS and the CDC, with significant control and compliance requirements. ACOG had to adhere to the federal government’s messaging that COVID-19 vaccines were safe and effective for pregnant women and new mothers. This funding was part of the larger “COVID-19 Community Corps” initiative, which enlisted trusted community leaders to promote vaccinations.

Trending: Shocking Discovery: Fani Willis Allegedly Connected to Large-Scale Election Fraud and Money Laundering Operation

Despite limited safety data, the CDC, followed by ACOG, recommended COVID-19 vaccination for pregnant women based on preliminary findings. ACOG’s influence in obstetrics meant that many healthcare providers followed its recommendations.

Dr. Thorp believed that ACOG’s acceptance of substantial funding from HHS was part of an arrangement that restricted them from deviating from CDC and HHS COVID policy narratives, as evidenced by the FOIA documents. Following his exposure to these financial incentives, Dr. Thorp was fired.

ACOG’s recommendations went beyond initial vaccinations and included booster shots, even though these vaccines lacked full FDA approval for pregnant women. Additionally, ACOG suggested simultaneous administration of COVID-19 vaccines with other vaccines despite the absence of clinical trial data supporting this practice.

It’s worth noting that the CDC discontinued its v-safe pregnancy registry, which collected data on vaccine safety during pregnancy, further limiting information on vaccine-associated risks for pregnant women.

In conclusion, ACOG’s acceptance of substantial funding from HHS raised questions about its influence and compliance with government COVID-19 vaccine messaging despite limited safety data for pregnant women. This situation highlights the complex interplay between medical organizations, government funding, and public health recommendations during the pandemic.